• Precision medicine using genetic testing to guide targeted therapies
• Access to the latest chemotherapy protocols and immunotherapies
• Advanced transplant techniques with improved donor matching and reduced complications
• State-of-the-art supportive care to reduce infections and treatment-related risks

Lymphoma

• Specialist-led protocols combining chemotherapy, targeted agents, and monoclonal antibodies
• Expertise in radiotherapy planning to achieve cure while protecting healthy tissues
• Availability of CAR-T cell therapy for resistant or relapsed cases
• Individualized treatment intensity based on lymphoma subtype and patient health

Myeloma

• Use of novel agents (proteasome inhibitors, immunomodulators, monoclonal antibodies)
• Expertise in high-dose chemotherapy and stem cell transplantation
• Advanced supportive therapies for bone health, kidney protection, and infection control
• Maintenance therapy planning to extend remission and improve survival

Myelodysplastic Syndromes (MDS)

• Specialist input in risk stratification and tailored treatment selection
• Access to novel hypomethylating agents and clinical trial drugs
• Expertise in managing transfusion dependence and iron overload
• Stem cell transplantation performed at specialized centers with improved success rates

Myeloproliferative Neoplasms (MPN)

• Use of advanced JAK inhibitors and precision medicines
• Multidisciplinary management to prevent blood clots and control symptoms
• Stem cell transplantation offered by expert teams for high-risk or advanced cases
• Ongoing monitoring with modern imaging and molecular testing to detect progression early